All results - Drugs and Technologies - electronic Medicines Compendium - eMC - Department of Health - Medicines Current Awareness - Quality Indicators | Evidence search

Revised SPC: Brinavess (vernakalant) 20 mg/ml concentrate for solution for infusion

Remove: electronic Medicines Compendium - eMC source - 31 October 2019 - Publisher: electronic Medicines compendium

SPC revised to state that for patients > 113 kg, a fixed dose of vernakalant is recommended. Initial dose is 339 mg; if conversion to sinus rhythm does not occur within 15 minutes after the end of...

Read Summary

- Remove: Medicines Current Awareness filter

- More: Guidance

Revised SPC: Fyremadel (ganirelix) solution for injection in pre-filled syringe

Remove: electronic Medicines Compendium - eMC source - 21 April 2020 - Publisher: electronic Medicines compendium

SPC now details that hypersensitivity reactions have been reported (frequency – very rare. Including rash, facial swelling, dyspnoea, anaphylaxis, anaphylactic shock, angioedema and urticaria).

Remove: Medicines Current Awareness filter

- More: Guidance

Revised SPC: Venofer (iron sucrose) 20 mg iron / ml solution for injection or concentrate for solution for infusion

Remove: electronic Medicines Compendium - eMC source - 25 November 2019 - Publisher: electronic Medicines compendium

SPC revised to warn foetal bradycardia may occur (though usually transient and a consequence of a hypersensitivity reaction in the mother) and the unborn baby should be carefully monitored during...

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Pelgraz (pegfilgrastim) 6 mg solution for injection in pre-filled syringe

Remove: electronic Medicines Compendium - eMC source - 05 December 2019 - Publisher: electronic Medicines compendium

SPC updated to include Stevens-Johnson syndrome, as a rare (=1/10,000 to <1/1,000) adverse effect of pegfilgrastim treatment. If the patient has developed SJS, SPC advises treatment with...

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Timoptol (timolol) preparations

Remove: electronic Medicines Compendium - eMC source - 17 December 2019 - Publisher: electronic Medicines compendium

Hallucination has been added as a potential adverse effect of treatment.

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Somatuline (lanreotide) preparations

Remove: electronic Medicines Compendium - eMC source - 17 December 2019 - Publisher: electronic Medicines compendium

SPC now highlights that there have been post-marketing reports of gallstones resulting in complications, including cholecystitis, cholangitis, and pancreatitis, requiring cholecystectomy. If...

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Emgality (galcanezumab) injection in pre-filled pen

Remove: electronic Medicines Compendium - eMC source - 17 December 2019 - Publisher: electronic Medicines compendium

SPC now advises that serious hypersensitivity reactions including cases of anaphylaxis, angioedema and urticaria have been reported. If a serious hypersensitivity reaction occurs, administration of...

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

New Product: Mayzent (siponimod fumaric acid) 0.25 mg and 2mg film-coated tablets

Remove: electronic Medicines Compendium - eMC source - 23 January 2020 - Publisher: electronic Medicines compendium

Siponimod fumaric acid is licensed for treatment of adults with secondary progressive multiple sclerosis with active disease evidenced by relapses or imaging features of inflammatory activity.

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

New product: Melatonin Pharma Nord 3mg film-coated tablets

Remove: electronic Medicines Compendium - eMC source - 22 January 2020 - Publisher: electronic Medicines compendium

This is licensed for the short-term treatment of jet-lag in adults. The standard dose is 3 mg daily for a maximum of 5 days. The dose may be increased to 6 mg if the standard dose does not adequately...

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Sivextro (tedizolid phosphate) 200 mg powder for concentrate for solution for infusion

Remove: electronic Medicines Compendium - eMC source - 22 January 2020 - Publisher: electronic Medicines compendium

SPC has been updated to provide clarification that when reconstituted/diluted, the solution should be stored between 2°C - 8°C when in a refrigerator.

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Filter results by

Results for all evidence | Drugs and Technologies | electronic Medicines Compendium - eMC | Medicines Current Awareness 1 - 10 of 264 sorted by relevance / date

Revised SPC: Brinavess (vernakalant) 20 mg/ml concentrate for solution for infusion

Revised SPC: Fyremadel (ganirelix) solution for injection in pre-filled syringe

Revised SPC: Venofer (iron sucrose) 20 mg iron / ml solution for injection or concentrate for solution for infusion

Revised SPC: Pelgraz (pegfilgrastim) 6 mg solution for injection in pre-filled syringe

Revised SPC: Timoptol (timolol) preparations

Revised SPC: Somatuline (lanreotide) preparations

Revised SPC: Emgality (galcanezumab) injection in pre-filled pen

New Product: Mayzent (siponimod fumaric acid) 0.25 mg and 2mg film-coated tablets

New product: Melatonin Pharma Nord 3mg film-coated tablets

Revised SPC: Sivextro (tedizolid phosphate) 200 mg powder for concentrate for solution for infusion